Compare RES & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RES | ATRC |
|---|---|---|
| Founded | 1984 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1995 | 2005 |
| Metric | RES | ATRC |
|---|---|---|
| Price | $6.60 | $27.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $5.64 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 1.6M | 836.6K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | N/A |
| Revenue | ★ $41,919,000,000.00 | $201,630,000.00 |
| Revenue This Year | $3.29 | $15.27 |
| Revenue Next Year | $4.05 | $12.21 |
| P/E Ratio | $45.40 | ★ N/A |
| Revenue Growth | ★ 2216.21 | 15.40 |
| 52 Week Low | $4.18 | $25.52 |
| 52 Week High | $8.16 | $43.18 |
| Indicator | RES | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 46.97 |
| Support Level | $6.42 | $26.47 |
| Resistance Level | $6.85 | $30.49 |
| Average True Range (ATR) | 0.25 | 1.20 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 7.05 | 57.88 |
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. Its operating segment includes Technical Services and Support Services. The Technical Services segment, which generates maximum revenue, comprises service lines that generate revenue based on equipment, personnel, or materials at the well site and are closely aligned with completion and production activities of the customers. The Support Services segment comprises service lines that generate revenue from services and equipment offered off the well site and are closely aligned with the customers' drilling activities.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.